Dianthus Therapeutics | MGTA - أصول متداولة





أصول متداولة تغيير تاريخ
Akebia Therapeutics USD 243.48M 9.47M 2026-03
Alaunos Therapeutics USD 970K 1.02M 2026-03
Avita Medical AUD 35.49M 760K 2025-12
Celltrion KRW 470.6B 5.07T 2025-12
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Divis Laboratories Ltd INR 98.43B 2.38B 2025-09
IQVIA Holdings USD 6.22B 29M 2026-03
Kangmei Pharma CNY 7.03B 128.34M 2025-09
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Moderna USD 5.77B 774M 2026-03
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 256.54M 28.35M 2025-12
Organon & Co USD 4.93B 580M 2026-03
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pharma Mar EUR 273.45M 9.96M 2026-03
Qiagen NV USD 2B 535.87M 2025-12
Revvity USD 2.13B 111.43M 2026-03
Sartorius EUR 1.92B 157.2M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Tilray USD 729.32M 28.18M 2025-09
Viatris USD 10.92B 1.13B 2026-03
Xeris Pharmaceuticals USD 251.68M 11.37M 2026-03
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03